Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guideline Platform
  3. Paediatrics
  4. Back
  5. Medical Paediatrics
  6. Vascular access devices (VADs), care and maintenance (592)
Announcements and latest updates

Right Decision Service newsletter: September 2024

Welcome to the Right Decision Service (RDS) newsletter for September 2024.

1.Business case for permanent provision of the Right Decision Service from April 2025 onwards

This business case has now been endorsed by the HIS Board and will shortly be submitted to Scottish Government.

2. Management of RDS support tickets

To balance increasing demand with available capacity and financial resource, the RDS team and Tactuum are now working together to  implement closer management of support tickets. As a key part of this, we want to ensure clear, timely and consistent communication with yourselves as requesters.  

Editors will now start seeing new messages come through in response to support ticket requests which reflect this tightening up and improvement of our processes.

Key points to note are:

2.1 Issues confirmed by the RDS and Tactuum teams as meeting the critical/urgent and high priority criteria will continue to be prioritised and dealt with immediately.

Critical/urgent issues are defined as:

  1. The Service as a whole is not operational for multiple users. OR
  2. Multiple core functions of the Service are not operational for multiple users.

Example – RDS website outage.

Please remember to email ann.wales3@nhs.scot and his.decisionsupport@nhs.scot with any critical/urgent issues in addition to raising a support ticket.

High priority issues are defined as:

  1. A single core function of the Service is not operational for multiple users. OR:
  2. Multiple non-core functions of the Service are not operational for multiple users.

Example – Build to app not working.

2.2 Support requests that are outwith the warranty period of 12 weeks since the software was originally developed will not be automatically addressed by Tactuum. The RDS team will consider these requests for costed development work and will obtain estimate of effort and cost from Tactuum for priority issues.

2.3 Support tickets for technical issues that are not classified as bugs will not be automatically addressed by Tactuum. The definition of a bug is ‘a defect in the software that is at variance with documented user requirements.’  Issues that are not bugs will also be considered for costed development work.

The majority of issues currently in support tickets fall into category 2 or 3 above, or both.

2.4 Non-urgent requests that require a deployment (i.e a new release of RDS) will normally be factored into the next scheduled release (currently end of Nov 2024 and end of Feb 2025) unless by special agreement with the RDS team.

Please note that we plan to move in the new year to a new system whereby requests all come to an RDS support portal in the first instance and are triaged from there to Tactuum when appropriate.

We will be organising a webinar in a few weeks’ time to take you through the details of the current support processes and criteria.

3. Next scheduled deployment.

The next scheduled RDS deployment will take place at the end of November 2024.  We are reviewing all outstanding support tickets and feature requests along with estimates of effort and cost to determine which items will be included in this deployment.

We will update you on this in the next newsletter and in the planned webinar about support ticket processes.

4. Contingency arrangements for RDS

Many thanks to those of you who attended our recent webinar on the contingency arrangements being put in place to prevent future RDS outages as far as possible and minimise impact if they do occur.  Please contact ann.wales3@nhs.scot if you would like a copy of the slides from this session.

5. Transfer of CKP pathways to RDS

The NES clinical knowledge pathway (CKP) publisher is now retired and the majority of pathways supported by this tool have been transferred to the RDS. Examples include:

NHS Lothian musculoskeletal pathways

NHS Fife rehabilitation musculoskeletal pathways

NHS Tayside paediatric pathways

6. Other new RDS toolkits

Include:

Focus on frailty (from HIS Frailty improvement programme)

NHS GGC Money advice and support

If you would like to promote one of your new toolkits through this newsletter, please contact ann.wales3@nhs.scot

To go live imminently:

  • Focus on dementia
  • NHS Lothian infectious diseases toolkit
  • Dumfries and Galloway Adult Support and Protection procedures
  • SIGN guideline – Prevention and remission of type 2 diabetes

 

7. Evaluation projects

We have recently analysed the results of a survey of users of the Scottish Palliative Care Guidelines toolkit.  Key findings from 61 respondents include:

  • Most respondents (64%) are frequent users of the toolkit, using it either daily or weekly. A further 25% use it once or twice per month.
  • 5% of respondents use the toolkit to deliver direct patient care and 82% use it for learning
  • Impact on practice and decision-making was rated as very high, with 80% of respondents rating these at a 4-5 on a 5 point scale.
  • Impact on time saving was also high, with 74% of respondents rating it from 3-5.
  • 74% also reported that the toolkit improved their knowledge and skills, rating these at 4-5 on the Likert scale

Key strengths identified included:

  • The information is useful, succinct, and easy to understand (31%).
  • Coverage is comprehensive (15%)
  • All information is readily accessible in one place and users value the offline access via mobile app (15%)
  • Information is reliable, evidence-based and up to date (13%)

Users highlighted key areas for improvement in terms of navigation and search functionality. The survey was very valuable in enabling us to uncover the specific issues affecting the user experience. Many of these can be addressed through content management approaches. The issues identified with search results echo other user feedback, and we are costing improvements with a view to implementation in the next RDS deployment.

8.RDS High risk prescribing (polypharmacy) decision support embedded in Vision and EMIS primary care E H R systems

This decision support software, sponsored by Scottish Government Effective Prescribing and Therapeutics Division,  is now available for all primary care clinicians across NHS Tayside. Board-wide implementation is also planned for NHS Lothian, and NHS GGC, NHS Ayrshire and Arran and NHS Dumfries and Galloway have initial pilots in progress. The University of Dundee has been commissioned to evaluate impact of this decision support software on prescribing practice.

9. Video tutorials for RDS editors

Ten bite-size (5 mins or less) video tutorials for RDS editors are now available in the “Resources for providers of RDS tools” section of the RDS.  These cover core functionality including Save and preview, content page and media management, password management and much more.

10. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Wednesday 23rd October 4-5 pm
  • Tuesday 29th October 11 am -12 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

 

Vascular access devices (VADs), care and maintenance (592)

Warning

This is the Vascular Access Procedure and Practice Guidelines for vascular access devices (VAD) incorporating NHS Greater Glasgow and Clyde (NHSGGC) adult (acute, mental health and community), paediatric and neonatal services. VADs are inserted for therapeutic purposes such as administration of intravenous (IV) fluids, medicines, blood transfusions and parenteral nutrition (PN). Other purposes for specific vascular access devices are renal dialysis, blood sampling and central venous pressure monitoring.

This document is organised with core introduction followed by care and maintenance templates. The information contained is based on current information available. Quality improvement, audit and research within clinical areas mean that this evidence base is constantly evolving. Practitioners should endeavour to use the most up-to-date evidence on which to base their practice.

The purpose of this guideline is to state the care and maintenance of the following VADs:

  • Peripheral Venous Catheter (PVC)
  • Midline catheter
  • Peripherally Inserted Central Catheter (PICC)
  • Non-Tunnelled Central Venous Catheter (CVC)
  • Tunnelled Central Venous Catheter (tCVC)
    • Uncuffed tCVC
    • Cuffed tCVC
  • Dialysis Central Venous Catheter
  • Implantable Ports

The detailed procedures for insertion of VADs are outside the scope of this guideline. Practitioners involved with insertion of VADs will be informed of where specific insertion procedure guidance can be found.

Patients with VADS are placed at increased risk of harm if not appropriately managed, for example healthcare associated infections and bloodstream infections are a significant cause of morbidity and mortality (NICE, 2014). Reports of mortality attributed to device related blood stream infections vary between 12.2% and 34.4% (Wong et al, 2016). VAD related bloodstream infections caused by inadequate device management significantly reduces the survival of patients in our care.

Patient harm can be reduced through:

  • Trained and competent staff
  • Adherence to relevant policies and guidance
  • Underpinning knowledge of different VADs
  • Good care and maintenance of VADs
  • Appropriate use of care bundles and accurate documentation (e.g. PVC and CVC care plans and patient held records)
  • Prevention, early recognition and management of complications
  • Inserting VAD only when clinically indicated and removing at earliest opportunity

Scope

This guideline is relevant to all NHSGGC health board staff that care for patients with a VAD.

This guideline should be used in conjunction with other relevant guidelines and standards:

  • Guidance for all adults receiving Parenteral Nutrition (home and in-patient) can be found  here.
  • Infection prevention and control guidelines can be found here.
  • NHSGGC IV Medicine Administration policy can be found here.
  • NHSGGC Management of occupational and non occupational exposures to blood borne viruses including needle stick injuries and sexual exposures policy can be found here.

Paediatric guidance:

  • Haemato-oncology patient’s fluid and electrolytes management (Schiehallion) can be found here
  • Intravenous fluid guidance for previously well children aged 7 days to 16 years can be found here.
  • Intravenous fluid therapy in children and young people in hospital can be found here.
  • West of Scotland Cancer Network Extravasation in Practice Guidelines, policy and tools can be found here.

Staff in specialist clinical areas caring for particularly vulnerable patient groups may have local standard operating procedures (SOP) in use which should be referred and adhered to.

Roles and responsibilities

For the care and maintenance of any VAD, staff should be appropriately trained and supervised until considered competent. A practitioner can be described as competent if they have had the necessary training, clinical experience, skills and knowledge to undertake a task safely and without supervision. If a practitioner deems it appropriate to adapt the guidelines, a risk assessment must be undertaken and documented appropriately.

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 28/04/2023

Next review date: 28/02/2025

Author(s): Margaret Connolly.

Version: 3

Author email(s): margaret.connolly@ggc.scot.nhs.uk.

Approved By: Board Clinical Governance Forum

Reviewer name(s): Margaret Connolly.

Document Id: 592